Preparation and identification of monoclonal antibodies against human LAG3 by immunizing mice with recombinant eukaryotic cell antigens.
- Author:
Xinyue LI
1
;
Xiu CAI
2
;
Yue JIN
3
,
4
Author Information
1. Department of Molecular Diagnostic Center, Northern Jiangsu People's Hospital, Yangzhou 225001; School of Medicine, Jiangsu University, Zhenjiang 212013, China.
2. School of Medicine, Jiangsu University, Zhenjiang 212013; Department of Clinical Laboratory, First People's Hospital of Yancheng, Yancheng 224000, China.
3. Department of Medical Experimental Center, Northern Jiangsu People's Hospital, Yangzhou 225001, China. *Corresponding author, E-mail: yyue_king @
4. com.
- Publication Type:Journal Article
- MeSH:
Animals;
Humans;
Mice;
Lymphocyte Activation Gene 3 Protein;
Antibodies, Monoclonal/immunology*;
Mice, Inbred BALB C;
Hybridomas/immunology*;
Antigens, CD/genetics*;
Immunization;
Recombinant Proteins/immunology*;
Female;
Eukaryotic Cells/immunology*;
Flow Cytometry;
Epitopes/immunology*
- From:
Chinese Journal of Cellular and Molecular Immunology
2024;40(12):1110-1114
- CountryChina
- Language:Chinese
-
Abstract:
Objective To prepare mouse anti-human lymphocyte activation gene 3 (LAG3) monoclonal antibody (mAb) and perform immunological identification of the antibody. Methods BALB/c mice were immunized with LAG3-mLumin-3T3 cells, which stably express the extracellular and transmembrane regions of human LAG3 in mouse 3T3 cells. The secretion of anti-human LAG3 antibodies in mouse serum was assessed using flow cytometry and immunofluorescence. SP2/0 cells were injected subcutaneously into the mice to elicit solid myelomas, and mouse myeloma cells were subsequently isolated. Spleen cells from the immunized mice were fused with the myeloma cells to establish hybridomas, which were then separated using the limiting dilution method. Flow cytometry was used to detect LAG3 mAbs in the hybridoma culture medium. To map the epitopes recognized by these mAbs, 3T3 cells expressing individual extracellular domains of LAG3(LAG3 domains 1/-2/-3/-4-3T3) were used. Flow cytometry was also applied to analyze LAG3 expression on activated human peripheral blood mononuclear cells (PBMC) before and after co-culture with the LAG3 mAbs. Results Mice immunized with the recombinant eukaryotic cell antigen produced anti-LAG3 antibodies. The generated hybridomas secreted mouse anti-human LAG3 mAbs, with each hybridoma line recognizing different LAG3 antigenic domains. Conclusion Mouse anti-human LAG3 mAbs were successfully generated, with different hybridoma clones secreting antibodies that recognize distinct LAG3 epitopes. These findings lay the groundwork for further studies into the biological properties of LAG3 and the development of diagnostic reagents and therapeutic blocking antibodies for cancer treatment.
